FI96856C - Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksiInfo
- Publication number
- FI96856C FI96856C FI903833A FI903833A FI96856C FI 96856 C FI96856 C FI 96856C FI 903833 A FI903833 A FI 903833A FI 903833 A FI903833 A FI 903833A FI 96856 C FI96856 C FI 96856C
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically useful
- aminoketone
- aminoketone derivatives
- derivatives
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract 2
- -1 Aminoketone derivative compounds Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20141089 | 1989-08-04 | ||
| JP20141089 | 1989-08-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI903833A0 FI903833A0 (fi) | 1990-08-01 |
| FI96856B FI96856B (fi) | 1996-05-31 |
| FI96856C true FI96856C (fi) | 1996-09-10 |
Family
ID=16440623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI903833A FI96856C (fi) | 1989-08-04 | 1990-08-01 | Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0414391B1 (fi) |
| JP (1) | JPH0625178B2 (fi) |
| KR (1) | KR920009062B1 (fi) |
| CN (1) | CN1040105C (fi) |
| AT (1) | ATE119890T1 (fi) |
| CA (1) | CA2022462A1 (fi) |
| DE (1) | DE69017794T2 (fi) |
| DK (1) | DK0414391T3 (fi) |
| FI (1) | FI96856C (fi) |
| NO (1) | NO180269C (fi) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338857A (en) * | 1989-08-04 | 1994-08-16 | Mitsui Toatsu Chemicals Incorporated | Aminoketone derivatives of 1,2-oxazole and use thereof |
| US5055585A (en) * | 1990-02-08 | 1991-10-08 | Mitsui Toatsu Chemicals, Incorporated | Preparation process of aminoketones |
| US5194606A (en) * | 1990-02-08 | 1993-03-16 | Mitsui Toatsu Chemicals, Incorporated | Preparation process of aminoketones |
| JP3164631B2 (ja) * | 1991-02-26 | 2001-05-08 | 三井化学株式会社 | 光学活性アミノケトン誘導体及びその製造法 |
| WO1996010567A1 (en) * | 1994-09-30 | 1996-04-11 | Maruho Co., Ltd. | Aminoketone derivative, physiologically acceptable salt thereof, and use of the same |
| US6214994B1 (en) | 1997-04-21 | 2001-04-10 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1′-yl propanones |
| US5693804A (en) * | 1994-11-17 | 1997-12-02 | Molecular Geriatrics Corporation | Substituted 1-aryl-3-piperazin-1'-yl propanones |
| DE10240026A1 (de) * | 2002-08-27 | 2004-03-11 | Merck Patent Gmbh | Verfahren zur Herstellung von Monoalkylaminoketonen |
| JP3789465B1 (ja) | 2005-04-28 | 2006-06-21 | 学校法人立教学院 | イソオキサゾール誘導体又はジヒドロイソオキサゾール誘導体の製造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE307581B (fi) * | 1963-07-31 | 1969-01-13 | Shionogi & Co | |
| JPS5862169A (ja) * | 1981-10-09 | 1983-04-13 | Nippon Kayaku Co Ltd | 新規な５−アミノイソオキサゾ−ル誘導体 |
| JPS58201770A (ja) * | 1982-05-18 | 1983-11-24 | Dainippon Pharmaceut Co Ltd | α−置換−１，２−ベンズイソキサゾ−ル−３−酢酸エステル類並びにその酸付加塩類及び第４級アンモニウム塩類 |
| AU4261285A (en) * | 1984-06-01 | 1985-12-05 | Tokyo Tanabe Company Limited | 1-propanone derivatives |
| JPH0637389B2 (ja) * | 1986-12-26 | 1994-05-18 | 北陸製薬株式会社 | 頻尿治療剤 |
| US4980365A (en) * | 1987-07-13 | 1990-12-25 | Hoechst-Roussel Pharmaceuticals Inc. | N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents |
| IE62276B1 (en) * | 1988-03-30 | 1995-01-25 | Sankyo Co | "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants" |
-
1990
- 1990-08-01 AT AT90308475T patent/ATE119890T1/de not_active IP Right Cessation
- 1990-08-01 DE DE69017794T patent/DE69017794T2/de not_active Expired - Fee Related
- 1990-08-01 FI FI903833A patent/FI96856C/fi not_active IP Right Cessation
- 1990-08-01 DK DK90308475.4T patent/DK0414391T3/da active
- 1990-08-01 JP JP2202528A patent/JPH0625178B2/ja not_active Expired - Lifetime
- 1990-08-01 EP EP90308475A patent/EP0414391B1/en not_active Expired - Lifetime
- 1990-08-01 CA CA002022462A patent/CA2022462A1/en not_active Abandoned
- 1990-08-03 NO NO903430A patent/NO180269C/no unknown
- 1990-08-04 CN CN90107939A patent/CN1040105C/zh not_active Expired - Fee Related
- 1990-08-04 KR KR1019900011987A patent/KR920009062B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU5998790A (en) | 1991-02-07 |
| DK0414391T3 (da) | 1995-04-03 |
| CN1049660A (zh) | 1991-03-06 |
| CN1040105C (zh) | 1998-10-07 |
| NO903430L (no) | 1991-02-05 |
| FI96856B (fi) | 1996-05-31 |
| JPH0625178B2 (ja) | 1994-04-06 |
| CA2022462A1 (en) | 1991-02-05 |
| KR920009062B1 (ko) | 1992-10-13 |
| NO180269C (no) | 1997-03-19 |
| EP0414391A2 (en) | 1991-02-27 |
| JPH03157375A (ja) | 1991-07-05 |
| ATE119890T1 (de) | 1995-04-15 |
| DE69017794T2 (de) | 1995-08-03 |
| DE69017794D1 (de) | 1995-04-20 |
| EP0414391B1 (en) | 1995-03-15 |
| NO903430D0 (no) | 1990-08-03 |
| FI903833A0 (fi) | 1990-08-01 |
| NO180269B (no) | 1996-12-09 |
| KR910004609A (ko) | 1991-03-29 |
| EP0414391A3 (en) | 1991-07-17 |
| AU615621B2 (en) | 1991-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI881103A0 (fi) | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi | |
| PT87552A (pt) | Process for the preparation of novel tetrazole intermediates toantihypertensive compounds | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| FI893750A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista | |
| ES2069137T3 (es) | Derivados de imidazopiridina y su uso. | |
| NO983487D0 (no) | Derivater av camptothecin for anvendelse ved behandling av kreft | |
| FI894477A7 (fi) | Menetelmä terapeuttisesti aktiivisten 7-substituoitujen 3,5-dihydroksihept-6-yynihappojen ja niiden johdannaisten valmistamiseksi ja välituotteina käyttökelpoiset yhdisteet | |
| FR2442845A1 (fr) | Derives amines spiranniques, leur preparation et leur utilisation comme medicaments | |
| NO169347C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider | |
| PT93552A (pt) | Processo para a preparacao de derivados de pirrol acriloil-substituidos e de composicoes farmaceuticas que os contem | |
| FI96856C (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi | |
| FI93106C (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi | |
| PT84716A (en) | Process for the preparation of insecticidal compositions containing six-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines | |
| FI895983A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi | |
| FI881104L (fi) | Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi | |
| SE9003973L (sv) | Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem | |
| ES2016464A6 (es) | Procedimiento para preparar derivados de 2', 5' -oligoadenilato. | |
| PT84718A (en) | Process for the preparation of insecticidal compositions containing five-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines | |
| KR880007070A (ko) | 백내장 치료용 약학 조성물 | |
| NO167978C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler. | |
| DE68921051D1 (de) | Pyridin-3-percarboxylsäure monopersulfat. | |
| FI103885B1 (fi) | Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä | |
| FI871479A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi | |
| PT86837A (pt) | Process for the preparation of novel heterocyclyl-2-propin-1-amines useful as dopamine beta-hydroxylase and of pharmaceutical compositions containing the same | |
| DE3883434D1 (de) | Mitomycinanaloge, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| PC | Transfer of assignment of patent |
Owner name: MITSUI CHEMICALS, INC. |
|
| MM | Patent lapsed |
Owner name: MITSUI CHEMICALS, INC. |